Skip to NavigationSkip to content

News

AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as a medical advance.
The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial pancreas' one step closer.
MPs have criticised a report recommending opening up community pharmacy to greater competition, saying its value had been misunderstood.
A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, still recovering from a generic...
AstraZeneca's new statin drug has received unanimous approval by a key FDA panel, and now looks set to be launched in the US market this year.
Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical industry demand...
Pharmaceutical companies should be allowed to set their own prices in all European Union countries in order to bring a single market one step closer...
GlaxoSmithKline has reached an agreement with Novartis in its court action over stolen trade secrets for its antibiotic Augmentin.
Cohn & Wolfe has been hired by GlaxoSmithKline to help NiQuitin CQ win the overall number one spot in the smoking cessation market.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches